年轻1型糖尿病患者基线尿酸与远期并发症的关联
研究基于瑞典DISS队列和NDR登记,分析15-34岁新诊断1型糖尿病患者的基线尿酸水平与远期大血管及微血管并发症的关系。中位随访19.0年后,发生并发症者基线尿酸显著更高(209.2±68.9 vs 171.7±50.2 µmol/l,p<0.001)。基线尿酸每升高1 µmol/l,并发症风险增加1%;最高四分位者风险增加超过三倍。
要点
- 新诊断1型糖尿病时尿酸较高者远期并发症风险显著增加
- 基线尿酸每升高1 µmol/l,并发症风险增加1%
- 最高四分位尿酸者并发症风险超过三倍(校正年龄、HbA1c、吸烟和eGFR后)
核心结论
- 新诊断1型糖尿病时较高的基线尿酸水平可能与远期大血管和微血管并发症相关。
研究设计与样本
- 基于瑞典全国DISS队列和NDR登记,纳入15-34岁新诊断1型糖尿病患者,基线检测尿酸,随访记录并发症。
- 发生并发症者94例,按诊断年份、年龄(±2岁)、性别和HbA1c匹配无并发症对照94例。
- 中位随访19.0年(IQR 16.3-21.0)。
主要发现
- 发生并发症者基线尿酸显著高于未发生者:209.2 ± 68.9 vs 171.7 ± 50.2 µmol/l(p<0.001)。
- 基线尿酸每升高1 μmol/l,发生并发症的比值增加1%。
- 校正年龄、HbA1c、吸烟和eGFR后,基线尿酸最高四分位者发生并发症的风险超过三倍。
临床怎么用
- 对于年轻新诊断1型糖尿病患者,可关注基线尿酸水平以识别远期并发症高风险个体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The aim of this work was to investigate whether baseline uric acid (UA) is associated with future complications among young individuals with newly diagnosed type 1 diabetes. METHODS: UA levels were analysed in individuals, aged 15-34 years with newly diagnosed type 1 diabetes, from the nationwide Diabetes Incidence Study in Sweden (DISS) cohort to assess the relationship with macro- and microvascular complications later in life. Information on complications was obtained by record linkage to the National Diabetes Registry of Sweden and the National Patient Registry of Sweden. Individuals who developed complications during follow-up (n = 94) were matched for year and age at diagnosis (±2 years), sex and HbA1c with control individuals (n = 94) without complications. RESULTS: Plasma UA levels at the time of diabetes diagnosis were significantly higher in individuals who later developed diabetes-related complications compared with those who did not, after a median follow-up of 19.0 years (IQR 16.3-21.0): 209.2 ± 68.9 vs 171.7 ± 50.2 µmol/l (p<0.001). The odds of developing complications were 1% higher for every 1 μmol/l rise in baseline UA, and individuals within the highest quartile of UA were more than three times more likely to develop diabetes-related complications later in life after adjusting for age, HbA1c, smoking and eGFR. CONCLUSIONS/INTERPRETATION: This study indicates that higher baseline UA levels at the time of type 1 diabetes diagnosis may be linked to both macrovascular and microvascular complications later in life.
引用
- Fagher K, Eeg-Olofsson K, Arnqvist H, et al. Uric acid and future complications in young individuals with type 1 diabetes: results from the Diabetes Incidence Study in Sweden (DISS) and the National Diabetes Registry of Sweden (NDR). Diabetologia. 2025. PMID: 41085706. doi:10.1007/s00125-025-06561-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。